
Uppsala Reports editor
@UMCGlobalSafety
Signal detection / 29 June 2021
Photo: iStock
UMC experts discuss how real-time vaccine surveillance works during a pandemic and the role of VigiBase in helping to ensure public safety.
With COVID-19 vaccinations rolling at full speed in many countries, there’s a lot of talk about vaccine safety monitoring. But what exactly does that mean and how should we be interpreting data on side effects? Uppsala Monitoring Centre’s Helena Sköld and Annette Rudolph walk us through the basics of vaccine pharmacovigilance.
Subscribe by visiting the Drug Safety Matters website or listen in right here:
Ever wondered how safety surveillance differs between vaccines and drugs? Find out in the latest episode of the Drug Safety Matters podcast.
25 August 2022
What are the implications for signal detection when new approaches to reporting create greater data streams than have ever been present for older medicinal products?
30 January 2023
South Africa’s pharmacovigilance system has been evolving for over a decade with UMC’s data management system supporting them every step of the way.
02 September 2024